Showing 1 - 13 results of 13 for search 'Anna Turkina', query time: 0.03s
Refine Results
-
1
Breastfeeding in patients with chronic myeloid leukaemia: case series with measurements of drug concentrations in maternal milk and review of literature by Ekaterina Chelysheva, Sergey Aleshin, Evgenia Polushkina, Roman Shmakov, Igor Shokhin, Ghermes Chilov, Anna Turkina
Published 2018-05-01
Article -
2
-
3
-
4
P677: THE FACTORS OF LATE MOLECULAR RELAPSES AFTER TYROSINE KINASE INHIBITORS DISCONTINUATION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA by Anna Petrova, Oleg Shukhov, Ekaterina Chelysheva, Margarita Gurianova, Irina Nemchenko, Anastasia Bykova, Elena Kuzmina, Anna Turkina
Published 2023-08-01
Article -
5
P655: LIMITATIONS OF USING CD26+ LEUKEMIA STEM CELL QUANTITATION IN CML PATIENTS TO ASSESS RESIDUAL LEUKEMIA CLONE by Nikolay Kapranov, Yulia Davydova, Kseniya Nikiforova, Irina Galtseva, Oleg Shukhov, Margarita Gurianova, Ekaterina Chelysheva, Anna Turkina
Published 2023-08-01
Article -
6
P682: THE RESULTS OF THE RUSSIAN PROSPECTIVE STUDY OF REDUCTION AND DISCONTINUATION TREATMENT OF TKI (READIT-2020) IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH DEEP MOLECULAR RESPONSE by Margarita Gurianova, Oleg Shukhov, Ekaterina Chelysheva, Anna Petrova, Anastasia Bykova, Irina Nemchenko, Elena Kuzmina, Lubov’ Gavrilova, Anna Turkina
Published 2023-08-01
Article -
7
Oral Galvanism Side Effects: Comparing Alloy Ions and Galvanic Current Effects on the Mucosa-like Model by Natalia Chepelova, Artem Antoshin, Sergei Voloshin, Anna Usanova, Yuri Efremov, Maria Makeeva, Stanislav Evlashin, Mikhail Stepanov, Anna Turkina, Peter Timashev
Published 2023-12-01
Article -
8
PB1975: ABL1 GENE DNA SEQUENCING IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA AND PH+ ACUTE LYMPHOBLASTIC LEUKEMIA. by Elena Kuzmina, Bella Biderman, Elena Stepanova, Ekaterina Chelysheva, Oleg Shukhov, Anna Petrova, Irina Nemchenko, Margarita Gurianova, Anastasia Bykova, Alina Kohno, Anna Turkina, Andrey Sudarikov
Published 2023-08-01
Article -
9
-
10
Asciminib add-on to imatinib demonstrates sustained high rates of ongoing therapy and deep molecular responses with prolonged follow-up in the ASC4MORE study by Timothy P. Hughes, Giuseppe Saglio, Jan Geissler, Dong-Wook Kim, Elza Lomaia, Jiri Mayer, Anna Turkina, Shruti Kapoor, Ana Paula Cardoso, Becki Nieman, Sara Quenet, Jorge E. Cortes
Published 2024-12-01
Article -
11
P673: ASCIMINIB MANAGMENT IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WITH T315I MUTATION. by Elena Kuzmina, Elza Lomaia, Elena Morozova, Ekaterina Chelysheva, Oleg Shukhov, Anna Petrova, Tamara Chitanava, Yulia Vlasova, Evgenia Sbityakova, Tayana Makarova, Irina Nemchenko, Anastasiya Bykova, Margarita Gurianova, Alina Kohno, Anna Turkina
Published 2023-08-01
Article -
12
Morphological Evaluation and Immunohistochemical Analysis of the Reparative Potential of the Buccal Fat Pad by Roman Zhidkov, Andrew Panin, Aleksei Drobyshev, Tatiana Demura, Sofya Avraamova, Petr Aleksandrov, Anastasia Kolesnikova, Hadi Darawsheh, Anna Turkina, Nicolai Redko, Yaroslav Skakunov, Elena Karpova, Anzhela Brago, Aleksandr Tsitsiashvili, Yuriy Vasil’ev
Published 2024-03-01
Article -
13
P662: POST HOC ANALYSIS OF PATIENT RESPONSES BY T315I MUTATION STATUS FROM THE 3-YEAR UPDATE OF THE OPTIC TRIAL: A DOSE-OPTIMIZATION STUDY OF 3 STARTING DOSES OF PONATINIB by Jorge Cortes, Michael Deininger, Elza Lomaia, Beatriz Moiraghi, Soledad Undurraga, Carolina Pavlovsky, Charles Chuah, Tomasz Sacha, Jeffrey H. Lipton, James Mccloskey, Philippe Rousselot, Gianantonio Rosti, Hugues de Lavallade, Christine Rojas, Anna Turkina, Moshe Talpaz, Michael Mauro, Vickie Lu, Alexander Vorog, Jane Apperley
Published 2023-08-01
Article